This site is intended for patients who have been prescribed Remicade (infliximab). If you are a Healthcare Professional then please visit the HCP site, or if you are a member of the public please visit our public site. This site is not a substitute for the Patient Information Leaflet (PIL). The information provided is general education information and does not take place of professional medical advice.

Any questions?

Here are the answers to some of the most commonly asked questions about taking Remicade (infliximab) for:

  • Rheumatoid arthritis (RA)
  • Psoriatic arthritis (PsA)
  • Ankylosing spondylitis (AS)
  • Psoriasis (PsO)
  • Crohn's disease (CD)
  • Ulcerative colitis (UC)
What effect will Remicade (infliximab) have on my other medications?

It is important to tell your healthcare professional if you are taking other medications, this includes non-prescription drugs, vitamins and herbal supplements. Before starting Remicade (infliximab), your healthcare professional will check your current medicines. You should not take Remicade (infliximab) with medicines containing the active substance anakinra or abatacept. Also, be sure your healthcare professional knows if you’re taking other medications that affect your immune system. If you see another doctor, nurse or dentist after you have started Remicade (infliximab), tell them that you are receiving this medicine.

What about diet, exercise and lifestyle choices?

Your healthcare professional is the best person to talk to regarding the diet and forms of exercise that best suit your condition. They will also be able to provide advice on smoking cessation and drinking. In addition, the patient support groups listed on the right can be a helpful source of information.

Can I take antibiotics while on Remicade (infliximab)?

Yes, but please make sure that the healthcare professional is aware that you are also receiving Remicade (infliximab).

Can I have vaccinations while on Remicade (infliximab)?

You should not receive certain vaccines while using Remicade (infliximab). Talk to your healthcare professional if you recently have had or are due to have a vaccine.

Can I go on holiday while on Remicade (infliximab)?

Yes, but it probably makes the most sense to travel in between your treatments. Talk to your healthcare professional about your travel plans before you go.

Can I drive while on Remicade (infliximab)?

Remicade (infliximab) is not likely to affect your ability to drive or use tools or machines. If you feel tired or unwell after having Remicade (infliximab), do not drive or use any tools or machines. You may wish to have someone drive you home after your first treatment. If you have no problems during and after your first treatment, you should be able to drive after future treatments. Check your insurance policy to make sure you are covered if you drive immediately after treatment.

Do I need to use contraception while on Remicade (infliximab)?

Yes, you should avoid getting pregnant when you are being treated with Remicade (infliximab) and for 6 months after you stop being treated with it. You should therefore discuss the use of contraception during this time with your doctor. If you are planning to start a family during or soon after your treatment, you should speak to your healthcare professional in advance.

Can I breastfeed while on Remicade (infliximab)?

Do not breastfeed during Remicade (infliximab) treatment, and for 6 months after stopping treatment.

Patient reminder card

Your patient reminder card contains important safety information. This should be read and carried with you and shown to any healthcare professional who is involved in your care. Please ask your healthcare professional for a patient reminder card if you do not have one.


Links to external sites

The link you have selected will take you to a third-party website. We do not review or control the content of any third-party site. We do not endorse and are not responsible for the accuracy, content, practices, or standards of any third-party sources.


  1. Kanai T et al. Korean J Intern Med 2014; 29(4): 409-15
  2. Olendzki BC et al. Nutr J 2014; 13(5): 1-7.
  3. Brown AC et al. Expert Rev. Gastroenterol. Hepatol 2011; 5(3): 411-25
  4. Pituch-Zdanowksa A et al. Prz Gastroenterol 2015; 10(3): 135-41.
  5. Oliviero F et al. Swiss Med Wkly 2015; 145: w14190.
  6. Clinton CM et al. Arthritis 2015; 2015: Article ID 708152.
  7. Narula N, Fedorak RN. Can J Gastroenterol 2008; 22 (5): 497-504
  8. Bilski J et al. BioMed Res Int 2014; Volume 2014 (Article ID 429031): 1-14.
  9. Benatti FB, Pedersen BK. Nat Rev Rheumatol 2015; 11: 86-97
  10. Nolte K et al. S Afr Fam Pract 2013; 55: 345-9
  11. Metsios GA et al. Expert Rev Clin Immunol 2015 [Epub ahead of print]
  12. Brophy S et al. Semin Arthritis Rheum 2013; 42: 619-26


For further information about Remicade (infliximab) please contact our Medical Information Department at:

Medical Information Department

Merck Sharp & Dohme (UK) Limited.

Registered Office: 120 Moorgate



United Kingdom

Tel: 01992 467272